Polaryx Therapeutics Insider Trades
NASDAQ: PLYXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 2 · $367.99K
- Sales
- 0 · $0
- Shares bought / sold
- 91.32K / 0
- Net activity
- Net buying $367,994
Polaryx Therapeutics insider activity
Over the last 12 months, Polaryx Therapeutics insiders reported 2 transactions on SEC Form 4: 2 open-market purchases and 0 sales. Insiders bought $367,994 and sold $0 worth of stock, for net insider buying of $367,994. The most recent filing shows Yang Alex Keun Mo & Mstone Partners Healthcare Ltd (Chief Executive Officer) buying 88,453 shares at $4.07 on May 27, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PLYX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
PLYX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 27, 2026 | Yang Alex Keun Mo & Mstone Partners Healthcare LtdChief Executive Officer | Buy | 88,453 | $360.00K | Form 4 |
| Feb 18, 2026 | Landis G. MichaelChief Financial Officer | Buy | 2,867 | $7.99K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4